Exenatide

Also known as: Byetta, Bydureon, Exendin-4

Synthetic exendin-4 (Gila monster venom peptide); GLP-1 receptor agonist that enhances insulin secretion and slows gastric emptying.

Typical dose
5 mcg – 10 mcg
Frequency
twice daily
Route
Subcutaneous
Half-life
2.4 hours
Routes
Subcutaneous
Status
FDA-approved for T2 diabetes
Track your Exenatide protocol in Vial →

Benefits

Dosing

A common research range for Exenatide is 5 mcg to 10 mcg twice daily. Extended-release: 2mg weekly; IR: 5-10mcg BID. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.

Half-life

Exenatide has an approximate half-life of 2.4 hours. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.

Storage

2-8°C before first use; room temp up to 30 days after.

Reported side effects

Contraindications

Track Exenatide with Vial

Vial logs every Exenatide dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →

This page is for educational and harm-reduction purposes only. Exenatide is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.